+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Glucuronolactone - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 150 Pages
  • May 2026
  • Region: Global
  • Mordor Intelligence
  • ID: 6248246
The glucuronolactone market size is expected to increase from USD 360.67 million in 2025 to USD 378.05 million in 2026 and reach USD 478.38 million by 2031, growing at a CAGR of 4.82% over 2026-2031, driven by sustained demand from energy drink producers and an expanding dietary supplement industry that has absorbed the compound's dual positioning as a detoxification aid and a performance enhancer. This report is Segmented by Form (Powder, Liquid), Application (Energy Drinks, Dietary Supplements and Nutraceuticals, Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Glucuronolactone Market Trends and Insights

Energy drink and functional beverage expansion

The energy drink category continues to create the single largest volume pull for the glucuronolactone market. Brands are expanding their product portfolios to cater to distinct consumer occasions such as hydration, focus, and recovery. Glucuronolactone's multifunctional profile, including detoxification, energy enhancement, and liver protection, enables its integration across various formulations, thereby increasing its average inclusion rate per unit volume. The growing demand for functional beverages, including energy drinks, is further driving the market. These beverages are increasingly targeting health-conscious consumers by incorporating ingredients such as glucuronolactone to enhance performance and deliver functional benefits. Additionally, the rise of clean-label and natural ingredient trends has encouraged manufacturers to innovate and reformulate products, creating new opportunities for glucuronolactone in the functional beverage segment. The global expansion of energy drink brands into emerging markets, coupled with aggressive marketing strategies, is expected to sustain the growth of this segment, making it a critical driver for the glucuronolactone market.

Rising demand for sports nutrition products

The rising demand for sports nutrition products is significantly driving the growth of the glucuronolactone market. Sports nutrition products, including energy drinks, recovery beverages, and functional supplements, are increasingly incorporating glucuronolactone due to its multifunctional benefits. Known for its detoxification, energy-boosting, and liver-protective properties, glucuronolactone has become a key ingredient in formulations for athletes and fitness enthusiasts. This trend is further supported by the growing consumer focus on health, wellness, and performance optimization. Sports nutrition is also expanding the application of glucuronolactone beyond traditional pre-workout energy drinks. HOWTIAN Group, for instance, has positioned D-glucuronolactone as a critical component in post-training recovery protocols. Its ability to enhance hepatic clearance of toxins accumulated during high-protein diets and stimulant-heavy training regimens makes it an ideal ingredient for recovery-focused products. This positioning is particularly significant as it creates new opportunities for glucuronolactone in post-session beverages and powders, diversifying its use cases and increasing its market penetration.

China-centric supply concentration and environmental compliance risk

Supply for D-glucuronolactone is heavily concentrated in Shandong province, China, a geography facing accelerating environmental compliance pressure. The Shandong Expanded Emerging Pollutant Controls (effective February 2026) add new monitoring and audit obligations for chemical manufacturers, while Central Environmental Inspection findings cited 7 chemical enterprises in Shandong for violations, including illegal expansion within protected river-management zones. For global buyers, this creates a dual risk: episodic supply disruption when non-compliant facilities are ordered to halt operations, and a sustained cost pass-through from producers investing in wastewater treatment and emissions controls. To mitigate these challenges, global buyers are exploring alternative sourcing options, particularly from Indian manufacturers such as Aadhunik Industries, Muby Chemicals, and Anmol Chemicals. However, diversification efforts remain limited, as China continues to dominate production, making it difficult to fully offset the risks associated with its supply concentration.

Other drivers and restraints analyzed in the detailed report include:
  • Innovation in low-sugar RTD formulations
  • Growing application in cognitive health and mental focus
  • Regulatory scrutiny on energy drinks
For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Powder held 64.27% of the glucuronolactone market share in 2025, reflecting its long-standing role in capsules, tablets, stick packs, and bulk premixes used by beverage manufacturers. The format remains favored because it is easier to ship, simpler to store, and more precise for dosing in pharmaceutical-grade and supplement production. The powder form offers extended shelf life and stability, making it a preferred choice for manufacturers aiming to maintain product quality over time. Its versatility in blending with other ingredients further enhances its adoption across applications such as energy drinks, dietary supplements, and functional foods. The powder segment also benefits from cost-effectiveness in large-scale production, which appeals to manufacturers seeking to achieve competitive pricing in the market.

Liquid is projected to grow at a 6.1% CAGR through 2031, placing it ahead of both the total glucuronolactone market and the powder segment. The faster growth stems from the strong shift toward ready-to-drink formats, especially zero-sugar energy beverages and functional shots. HOWTIAN Group, which produces 2,000 tons of D-glucuronolactone annually, explicitly promotes its liquid-compatible solubility and flavor neutrality as formulation advantages for Ready-to-Drink (RTD) beverage brands. The liquid-form advantage also extends to effervescent powders and stick-pack dissolvable formats targeted at sports recovery and gaming nutrition, both of which demand rapid dissolution.

Complete Report Scope:

  • By Form
    • Powder
    • Liquid
  • By Application
    • Energy Drinks
    • Dietary Supplements and Nutraceuticals
    • Pharmaceuticals
    • Cosmetics and Personal Care
    • Food and Beverage
  • By Geography
    • North America
      • United States
      • Mexico
      • Rest of North America
    • Europe
      • United Kingdom
      • Germany
      • France
      • Rest of Europe
    • Asia-Pacific
      • India
      • China
      • Japan
      • Rest of Asia-Pacific
    • South America
    • Middle East and Africa

Geography Analysis

North America held 37.08% of the glucuronolactone market share in 2025, which made it the largest regional demand center. The United States drives most of that volume through its large energy drink base, mature sports nutrition retail network, and steady demand for daily wellness supplements. The partnership between Anheuser-Busch and 1st Phorm showed how closely energy beverages and sports nutrition are moving together in the market. The region also keeps an advantage over Europe because the United States does not have a federal age restriction or caffeine cap for energy drinks, which preserves a wider addressable base.

Asia-Pacific is projected to grow at a 6.25% CAGR through 2031, making it the fastest-growing regional market and the leading growth engine for the glucuronolactone market. China remains central because it combines a major manufacturing base with rising domestic demand for energy drinks, supplements, and pharmaceutical-grade intermediates. India is emerging as a secondary supply node, with domestic nutraceutical demand growing and local chemical producers widening their specialty ingredient offerings. Japan adds a premium channel because strict compliance with functional food and supplement regulations supports higher-value, pharmaceutical-grade sales. South America and the Middle East and Africa still contribute a smaller share today, but export-oriented distribution networks already active in these regions suggest a better platform for future glucuronolactone market expansion.

Europe remains an important market for food, pharmaceutical, and specialty ingredient demand, but regulations are becoming increasingly restrictive. By 2025, several European countries had already restricted the sale of energy drinks to minors, and the UK consultation published in September 2025 pointed to further pressure ahead. This is pushing innovation toward adult-focused functional beverages that retain the ingredient stack while softening the energy drink label. Jungbunzlauer’s 2025 move into Illinois also showed that European-headquartered suppliers are shifting production footprints outward to reduce regional concentration risk



List of Companies Covered in this Report:

  • Jungbunzlauer Suisse AG
  • Roquette Frères
  • Merck KGaA (MilliporeSigma)
  • Foodchem International Corporation
  • Hubei Yitai Pharmaceutical Co., Ltd.
  • Actylis
  • HOWTIAN Group
  • Hefei TNJ Chemical Industry Co., Ltd.
  • Aadhunik Industries
  • Muby Chemicals
  • Aceto Corporation
  • Fengchen Group Co., Ltd.
  • Samex Overseas
  • Zouping Mingxing Chemical Co., Ltd.
  • Prinova Group
  • Biosynth
  • Hunan NutraMax Inc.
  • Shaanxi Sciphar Natural Products Co., Ltd.
  • Ataman Kimya A.Ş.
  • Niran Bio

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Energy drink and functional beverage expansion
4.2.2 Dietary supplement and liver-support uptake
4.2.3 Rising demand for sports nutrition products
4.2.4 Innovation in low-sugar RTD formulations
4.2.5 Gamer and nootropic product penetration
4.2.6 Growing application in cognitive health and mental focus
4.3 Market Restraints
4.3.1 Health concerns associated with high-dose consumption
4.3.2 China-centric supply concentration and environmental compliance risk
4.3.3 Growth of substitute functional ingredients
4.3.4 Regulatory scrutiny on energy drinks
4.4 Supply Chain Analysis
4.5 Regulatory Outlook
4.6 Porter's Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE & GROWTH FORECASTS (VALUE)
5.1 By Form
5.1.1 Powder
5.1.2 Liquid
5.2 By Application
5.2.1 Energy Drinks
5.2.2 Dietary Supplements and Nutraceuticals
5.2.3 Pharmaceuticals
5.2.4 Cosmetics and Personal Care
5.2.5 Food and Beverage
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Mexico
5.3.1.3 Rest of North America
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 France
5.3.2.4 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 India
5.3.3.2 China
5.3.3.3 Japan
5.3.3.4 Rest of Asia-Pacific
5.3.4 South America
5.3.5 Middle East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Ranking Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 Jungbunzlauer Suisse AG
6.4.2 Roquette Frères
6.4.3 Merck KGaA (MilliporeSigma)
6.4.4 Foodchem International Corporation
6.4.5 Hubei Yitai Pharmaceutical Co., Ltd.
6.4.6 Actylis
6.4.7 HOWTIAN Group
6.4.8 Hefei TNJ Chemical Industry Co., Ltd.
6.4.9 Aadhunik Industries
6.4.10 Muby Chemicals
6.4.11 Aceto Corporation
6.4.12 Fengchen Group Co., Ltd.
6.4.13 Samex Overseas
6.4.14 Zouping Mingxing Chemical Co., Ltd.
6.4.15 Prinova Group
6.4.16 Biosynth
6.4.17 Hunan NutraMax Inc.
6.4.18 Shaanxi Sciphar Natural Products Co., Ltd.
6.4.19 Ataman Kimya A.S.
6.4.20 Niran Bio
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Jungbunzlauer Suisse AG
  • Roquette Frères
  • Merck KGaA (MilliporeSigma)
  • Foodchem International Corporation
  • Hubei Yitai Pharmaceutical Co., Ltd.
  • Actylis
  • HOWTIAN Group
  • Hefei TNJ Chemical Industry Co., Ltd.
  • Aadhunik Industries
  • Muby Chemicals
  • Aceto Corporation
  • Fengchen Group Co., Ltd.
  • Samex Overseas
  • Zouping Mingxing Chemical Co., Ltd.
  • Prinova Group
  • Biosynth
  • Hunan NutraMax Inc.
  • Shaanxi Sciphar Natural Products Co., Ltd.
  • Ataman Kimya A.Ş.
  • Niran Bio